| Literature DB >> 25837195 |
Sung-Jin Choi1, Kyung-Jin Yeum2, Soo-Jung Park1, Beomhee Choi3, Nam-Seok Joo4.
Abstract
PURPOSE: The association between excess calcium intake and cardiovascular mortality has already been reported. In the present study, we investigated the relation between dietary calcium intake and Framingham Risk Score (FRS) according to serum 25-hydroxyvitamin D [25(OH)D] status.Entities:
Keywords: 25-hydroxyvitamin D; calcium; coronary disease
Mesh:
Substances:
Year: 2015 PMID: 25837195 PMCID: PMC4397459 DOI: 10.3349/ymj.2015.56.3.845
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1Flow diagram of subject inclusion and exclusion in the Korea National Health and Nutrition Examination Surveys. This figure shows the selection of study subjects in the KNHANES 2008-2011. KNHANES, Korea National Health and Nutrition Examination Survey.
General Characteristics of Study Subjects by Dietary Calcium Intake Groups
| Variables | Dietary calcium intake (mg/day) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male (n=3452) | Female (n=4357) | |||||||||||
| <300 | 300-600 | 600-900 | 900-1200 | >1200 | <300 | 300-600 | 600-900 | 900-1200 | >1200 | |||
| Subjects (n) | 714 | 1574 | 751 | 255 | 158 | 1618 | 1807 | 617 | 205 | 110 | ||
| Age (yrs) | 57.4 (0.6) | 52.7 (0.3) | 51.8 (0.3) | 51.8 (0.7) | 52.7 (0.9) | <0.001 | 57.3 (0.4) | 53.1 (0.3) | 51.8 (0.4) | 52.2 (0.7) | 53.5 (1.1) | <0.001 |
| BMI (kg/m2) | 23.5 (0.2) | 24.1 (0.1) | 24.2 (0.1) | 24.2 (0.2) | 24.8 (0.3) | 0.001 | 24.0 (0.1) | 24.0 (0.1) | 23.5 (0.1) | 23.8 (0.2) | 23.3 (0.4) | 0.051 |
| Energy (kcal/day) | 1644.7 (26.6) | 2173.2 (22.3) | 2597.0 (33.9) | 2815.1 (62.7) | 3127.1 (90.5) | <0.001 | 1278.9 (12.8) | 1676.7 (15.5) | 1954.5 (32.9) | 2144.0 (57.0) | 2369.6 (79.8) | <0.001 |
| 25(OH)D (nmol/L) | 50.7 (1.0) | 52.0 (0.7) | 51.2 (0.8) | 52.3 (1.2) | 52.6 (2.0) | 0.660 | 42.6 (0.6) | 43.4 (0.6) | 43.4 (0.8) | 43.1 (1.4) | 49.0 (2.1) | 0.070 |
| HTN (n) (%) | 188 (22.5) | 375 (45.1) | 174 (20.8) | 54 (6.5) | 43 (5.1) | 0.385 | 475 (44.6) | 426 (40.1) | 108 (10.2) | 38 (3.5) | 17 (1.6) | <0.001 |
| SBP (mm Hg) | 123.0 (0.9) | 121.6 (0.6) | 119.7 (0.6) | 120.3 (1.3) | 121.7 (1.3) | 0.026 | 122.1 (0.6) | 118.9 (0.5) | 115.2 (0.8) | 118.8 (1.3) | 118.4 (2.0) | <0.001 |
| DBP (mm Hg) | 78.4 (0.6) | 79.6 (0.4) | 79.1 (0.5) | 78.4 (0.8) | 79.3 (0.8) | 0.296 | 76.0 (0.3) | 75.6 (0.3) | 74.0 (0.5) | 76.0 (0.8) | 75.1 (1.2) | 0.009 |
| Glucose (mmol/L) | 5.49 (0.06) | 5.49 (0.03) | 5.49 (0.05) | 5.49 (0.06) | 5.87 (0.27) | 0.734 | 5.35 (0.03) | 5.28 (0.02) | 5.20 (0.04) | 5.17 (0.05) | 5.23 (0.07) | 0.002 |
| Insulin (uIU/mL) | 9.8 (0.3) | 9.5 (0.2) | 9.8 (0.3) | 9.7 (0.4) | 10.2 (0.6) | 0.725 | 10.2 (0.2) | 10.1 (0.1) | 10.0 (0.5) | 9.8 (0.3) | 9.0 (0.5) | 0.301 |
| TC (mmol/L) | 4.91 (0.04) | 5.01 (0.03) | 4.96 (0.04) | 5.07 (0.08) | 5.13 (0.14) | 0.164 | 5.06 (0.03) | 5.05 (0.02) | 5.01 (0.05) | 5.01 (0.07) | 5.23 (0.10) | 0.346 |
| HDL (mmol/L) | 1.25 (0.01) | 1.29 (0.01) | 1.27 (0.01) | 1.28 (0.03) | 1.23 (0.03) | 0.083 | 1.38 (0.01) | 1.40 (0.01) | 1.43 (0.02) | 1.41 (0.02) | 1.49 (0.03) | 0.002 |
| TG (mmol/L) | 1.86 (0.06) | 1.88 (0.05) | 1.89 (0.08) | 1.84 (0.10) | 2.43 (0.33) | 0.567 | 1.45 (0.03) | 1.38 (0.03) | 1.18 (0.03) | 1.35 (0.06) | 1.24 (0.09) | <0.001 |
| FRS (points)/10-yr risk (%) | 11.5 (0.2)/10 | 10.5 (0.1)/8 | 10.2 (0.2)/6 | 9.9 (0.3)/6 | 11.1 (0.3)/8 | <0.001 | 12.0 (0.2)/1 | 10.0 (0.2)/1 | 9.1 (0.2)/1 | 9.6 (0.4)/1 | 10.0 (0.6)/1 | <0.001 |
BMI, body mass index; HTN, hypertension; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; HDL, high density lipoprotein; TG, triglyceride; FRS, Framingham Risk Score; Energy, total calorie intake; Calcium, daily intake; serum 25(OH)D, serum 25-hydroxyvitamin D concentration.
Data represent mean (standard error).
p values represent P for trends by ANOVA test without adjustment.
Difference of Framingham Risk Score by Calcium Intake Groups
| Calcium intake (mg/day) | ||||||
|---|---|---|---|---|---|---|
| <300 | 300-600 | 600-900 | 900-1200 | >1200 | ||
| Male | 11.1 (0.2)/714 | 10.5 (0.1)/1574 | 10.4 (0.2)/751 | 10.2 (0.3)/255 | 11.1 (0.3)/158 | <0.001 |
| Female | 10.3 (0.1)/1618 | 9.4 (0.1)/1807 | 9.2 (0.2)/617 | 9.4 (0.3)/204 | 10.7 (0.5)/110 | <0.001 |
BMI, body mass index; 25(OH)D, 25-hydroxyvitamin D.
All values represent Framingham Risk Score (SE)/subject numbers. P for trend was obtained by ANCOVA test after adjustments for age, BMI, jobs, education, smoking status, alcohol intake, moderate physical activity, serum 25(OH)D and total calories intakes for both genders. Menopause, oral contraceptives and hormone replacement therapy were also adjusted for with women.
Fig. 2Framingham Risk Score according to the dietary calcium intake and serum 25(OH)D. p-values were obtained by ANCOVA test after adjustments for age, BMI, jobs, education, smoking status, alcohol intake, moderate physical activity, serum 25(OH)D, total calories intakes and season for both genders (A: men, B: women). Menopause, oral contraceptives and hormone replacement therapy were also adjusted for with women. BMI, body mass index; 25(OH)D, 25-hydroxyvitamin D.